141 related articles for article (PubMed ID: 12100744)
1. Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.
Yassaee VR; Zeinali S; Harirchi I; Jarvandi S; Mohagheghi MA; Hornby DP; Dalton A
Breast Cancer Res; 2002; 4(4):R6. PubMed ID: 12100744
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso.
Biancolella M; Ouédraogo NLM; Zongo N; Zohoncon TM; Testa B; Rizzacasa B; Latini A; Conte C; Compaore TR; Ouedraogo CMR; Traore SS; Simpore J; Novelli G
Hum Genomics; 2021 Oct; 15(1):65. PubMed ID: 34717758
[TBL] [Abstract][Full Text] [Related]
3. Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.
Torres-Mejía G; Royer R; Llacuachaqui M; Akbari MR; Giuliano AR; Martínez-Matsushita L; Angeles-Llerenas A; Ortega-Olvera C; Ziv E; Lazcano-Ponce E; Phelan CM; Narod SA
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):498-505. PubMed ID: 25371446
[TBL] [Abstract][Full Text] [Related]
4. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Edwards SM; Kote-Jarai Z; Meitz J; Hamoudi R; Hope Q; Osin P; Jackson R; Southgate C; Singh R; Falconer A; Dearnaley DP; Ardern-Jones A; Murkin A; Dowe A; Kelly J; Williams S; Oram R; Stevens M; Teare DM; Ponder BA; Gayther SA; Easton DF; Eeles RA; ;
Am J Hum Genet; 2003 Jan; 72(1):1-12. PubMed ID: 12474142
[TBL] [Abstract][Full Text] [Related]
5. BRCA2 T2722R is a deleterious allele that causes exon skipping.
Fackenthal JD; Cartegni L; Krainer AR; Olopade OI
Am J Hum Genet; 2002 Sep; 71(3):625-31. PubMed ID: 12145750
[TBL] [Abstract][Full Text] [Related]
6. BRCA mutation testing in determining breast cancer therapy.
Smith KL; Isaacs C
Cancer J; 2011; 17(6):492-9. PubMed ID: 22157293
[TBL] [Abstract][Full Text] [Related]
7. Detection of a novel mutation in exon 20 of the BRCA1 gene.
Chakraborty A; Katarkar A; Chaudhuri K; Mukhopadhyay A; Basak J
Cell Mol Biol Lett; 2013 Dec; 18(4):631-8. PubMed ID: 24297685
[TBL] [Abstract][Full Text] [Related]
8. Referencing BRCA in hereditary cancer risk discussions: In search of an anchor in a sea of uncertainty.
Waltz M; Prince AER; O'Daniel JM; Foreman AKM; Powell BC; Berg JS
J Genet Couns; 2020 Dec; 29(6):949-959. PubMed ID: 31967382
[TBL] [Abstract][Full Text] [Related]
9. Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).
Tram E; Ibrahim-Zada I; Briollais L; Knight JA; Andrulis IL; Ozcelik H
Breast Cancer Res; 2011 Aug; 13(4):R77. PubMed ID: 21835029
[TBL] [Abstract][Full Text] [Related]
10. Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nik-Zainal S; Davies H; Staaf J; Ramakrishna M; Glodzik D; Zou X; Martincorena I; Alexandrov LB; Martin S; Wedge DC; Van Loo P; Ju YS; Smid M; Brinkman AB; Morganella S; Aure MR; Lingjærde OC; Langerød A; Ringnér M; Ahn SM; Boyault S; Brock JE; Broeks A; Butler A; Desmedt C; Dirix L; Dronov S; Fatima A; Foekens JA; Gerstung M; Hooijer GK; Jang SJ; Jones DR; Kim HY; King TA; Krishnamurthy S; Lee HJ; Lee JY; Li Y; McLaren S; Menzies A; Mustonen V; O'Meara S; Pauporté I; Pivot X; Purdie CA; Raine K; Ramakrishnan K; Rodríguez-González FG; Romieu G; Sieuwerts AM; Simpson PT; Shepherd R; Stebbings L; Stefansson OA; Teague J; Tommasi S; Treilleux I; Van den Eynden GG; Vermeulen P; Vincent-Salomon A; Yates L; Caldas C; van't Veer L; Tutt A; Knappskog S; Tan BK; Jonkers J; Borg Å; Ueno NT; Sotiriou C; Viari A; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Birney E; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Stratton MR
Nature; 2016 Jun; 534(7605):47-54. PubMed ID: 27135926
[TBL] [Abstract][Full Text] [Related]
11. ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
Renault AL; Lesueur F; Coulombe Y; Gobeil S; Soucy P; Hamdi Y; Desjardins S; Le Calvez-Kelm F; Vallée M; Voegele C; ; Hopper JL; Andrulis IL; Southey MC; John EM; Masson JY; Tavtigian SV; Simard J
PLoS One; 2016; 11(6):e0156820. PubMed ID: 27270457
[TBL] [Abstract][Full Text] [Related]
12. Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test?
Kratz CP; Lupo PJ; Zelley K; Schienda J; Nichols KE; Stewart DR; Malkin D; Brodeur GM; Maxwell K; Plon SE; Walsh MF
Clin Cancer Res; 2024 May; 30(9):1733-1738. PubMed ID: 38411636
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 Gene Mutations in Breast Cancer Patients from Kerman Province, Iran.
Saleh-Gohari N; Mohammadi-Anaie M; Kalantari-Khandani B
Iran J Cancer Prev; 2012; 5(4):210-5. PubMed ID: 25352972
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families.
Pietschmann A; Mehdipour P; Mehdipour P; Atri M; Hofmann W; Hosseini-Asl SS; Scherneck S; Mundlos S; Peters H
J Cancer Res Clin Oncol; 2005 Aug; 131(8):552-8. PubMed ID: 15918047
[TBL] [Abstract][Full Text] [Related]
15. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
[TBL] [Abstract][Full Text] [Related]
16. An analysis of unclassified missense substitutions in human BRCA1.
Tavtigian SV; Samollow PB; de Silva D; Thomas A
Fam Cancer; 2006; 5(1):77-88. PubMed ID: 16528611
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.
Kim TJ; Lee KM; Choi CH; Lee JW; Lee JH; Bae DS; Kim BG
Oncol Rep; 2006 Mar; 15(3):565-9. PubMed ID: 16465413
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms.
Pettigrew C; Wayte N; Lovelock PK; Tavtigian SV; Chenevix-Trench G; Spurdle AB; Brown MA
Breast Cancer Res; 2005; 7(6):R929-39. PubMed ID: 16280041
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the estrogen receptor-alpha gene in familial ovarian cancer.
Wu HJ; Sekine M; Kashima K; Hirai Y; Hatae M; Kobayashi I; Obata K; Enomoto T; Umesaki N; Ushijima K; Tanaka K;
J Obstet Gynaecol Res; 2005 Oct; 31(5):375-83. PubMed ID: 16176503
[TBL] [Abstract][Full Text] [Related]
20. Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis.
Velasco E; Infante M; Durán M; Esteban-Cardeñosa E; Lastra E; García-Girón C; Miner C
Electrophoresis; 2005 Jun; 26(13):2539-52. PubMed ID: 15937982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
